je.st
news
Tag: fda
09.05.14 -- FDA Breakthrough Therapy Designation For NUPLAZID For Parkinson's Disease Psychosis
2014-09-04 06:24:13| drugdiscoveryonline Home Page
09/05/14 Drug Discovery Online Newsletter
Tags: disease
therapy
designation
breakthrough
Black Bridge Foods fish products pass food safety standards, says FDA
2014-09-04 01:00:00| Food Processing Technology
The Food and Drugs Administration (FDA) department of Taiwan has declared that the materials used by Black Bridge Foods in processed food items have passed local safety standards, contrasting recent findings of Hong Kong authorities that the company
Tags: products
black
food
safety
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine
2014-09-03 12:22:48| drugdiscoveryonline Home Page
Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds
Tags: review
application
license
acceptance
ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation For NUPLAZID (Pimavanserin) For Parkinson's Disease Psychosis
2014-09-03 11:32:21| drugdiscoveryonline Home Page
ACADIA Pharmaceuticals Inc. a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID (pimavanserin) for the treatment of Parkinson’s disease psychosis
Tags: disease
therapy
receives
designation
Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs
2014-09-01 09:56:36| Biotech - Topix.net
Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product status from U.S. Food & Drug Administration .
Tags: status
drugs
receives
fda
Sites : [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] next »